Drug Trial Radar · NCT06570460
Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome
Last checked: Nov 20, 2026Latest source record: Aug 26, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Nov 29, 2021
Primary completion
Dec 31, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Aarhus University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Aarhus
- First posted
- Aug 26, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This 14-month, phase IV, randomized controlled crossover trial aims to compare the effects of oral versus transdermal estrogen replacement therapy (ERT) in women with Turner syndrome (TS). The study's objectives are to clarify endocrine, metabolic, cardiovascular, and thromboembolic risk factors in TS after a wash-out period without estrogen (E2) treatment; compare the effects of oral versus transdermal (TD) ERT regimens; and examine the long-term effects of E2 administration via these two routes. The study involves 50 TS women aged 18-50 years and 50 control participants. TS participants are randomized to receive either oral or TD ERT for six months, followed by crossover to the alternate treatment for another six months. Prior to randomization, any existing ERT will be discontinued for a 1-month washout period. A second 1-month washout period will occur between the two 6-month treatment phases. Laboratory analyses and clinical investigations are performed after the first wash-out period, after the first six months of treatment, and after the last six months of treatment. We anticipate that this study may provide a basis for new and improved recommendations for sex hormone replacement therapy in TS.
Conditions
- Turner Syndrome
- Hypogonadism; Ovarian
- Hormone Replacement Therapy
- Estrogen Replacement Therapy
- Estrogen Deficiency
Interventions
17-beta estradiolDrug
Treatment with orally administered estrogen for 6 months
17-beta estradiolDrug
Treatment with transdermally administered estrogen for 6 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Blood test valuesTime frame: After 1 month of wash-out, 6 months of oral and six months of transdermal treatment
- Blood test valuesTime frame: After 1 month of wash-out, 6 months of oral and six months of transdermal treatment
- Dual energy X-ray absorptiometryTime frame: After 6 months of oral and six months of transdermal treatment
- Cardiovascular statusTime frame: After 6 months of oral and six months of transdermal treatment
- Cardiovascular statusTime frame: After 6 months of oral and six months of transdermal treatment
- Muscle quality (quadriceps femoris)Time frame: After 6 months of oral and six months of transdermal treatment
- Functional muscle testsTime frame: After 6 months of oral and six months of transdermal treatment
- Isometric muscle testsTime frame: After 6 months of oral and six months of transdermal treatment
- Maximal oxygen uptake test (VO2 max)Time frame: After 6 months of oral and six months of transdermal treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Endocrinology and Internal Medicine, Aarhus University Hospital
Aarhus, Aarhus N, Denmark · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.